- Bladder Cancer Today
- Dedication
- Epidemiology and genetic susceptibility to bladder cancer
- Bladder cancer, pathological classification and staging
- Genomics: a preview of genomic medicine
- The past, present and future of cystoscopy: the fusion of cystoscopy and novel imaging technology
- Urothelial bladder cancer: biomarkers for detection and screening
- Quality control in transurethral resection of bladder tumours
- Risk-adapted use of intravesical chemotherapy
- Risk-adapted use of intravesical immunotherapy
- The optimal management of T1G3 bladder cancer
- Chemoprevention of bladder cancer
- Outcomes of radical cystectomy
- Cystectomy in women
- Laparoscopic radical cystectomy for muscle-invasive bladder cancer: pathological and oncological outcomes
- Aetiology, diagnosis and management of urothelial tumours of the renal pelvis and ureter
- The orthotopic neobladder
- Continent cutaneous diversion
- Incontinent urinary diversion
- Urinary diversion: evidence-based outcomes assessment and integration into patient decision-making
- Biocompatible materials for bladder substitution
- Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer
- Bladder preservation: optimizing radiotherapy and integrated treatment strategies
- Treatment of metastatic urothelial cancer: opportunities for drug discovery and development
